Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (51-60 of 405) with videos related to

Pageof 41
Sort By:
Kardiologia Polska|May 6, 2022
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advancesDan Atar, Gisle Langslet, Serena Tonstad
Harefuah|November 8, 2002
[Fracture of the supracondylar process of the humerus associated with Monteggia fracture]Gad Kahn, Ehud Rath, Dan Atar
The New England Journal of Medicine|February 18, 2026
Beta-Blockers after Myocardial Infarction. ReplyJohn Munkhaugen, Dan Atar, Eva Prescott
Kardiologia Polska|May 5, 2023
Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarctionDan Atar, Arnhild Bakken, John Munkhaugen
Internal and Emergency Medicine|April 9, 2024
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigmAndrea Rubboli, Dan Atar, Dirk Sibbing
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 3, 2013
New oral anticoagulants--a reviewWaleed Ghanima, Dan Atar, Per Morten Sandset
The American Journal of Cardiology|March 14, 2007
Mechanism of troponin elevations in patients with acute ischemic strokeJesper K Jensen, Dan Atar, Hans Mickley
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 1, 2020
Intensification of antithrombotic therapy for chronic atherosclerosisMarita Knudsen Pope, Waleed Ghanima, Dan Atar
The American Journal of Medicine|July 30, 2019
Challenging Anticoagulation in Advanced Renal FailureHanz-Peter Marti, Victor Serebruany, Dan Atar
European Heart Journal|August 2, 2023
Cardiac device infection: removing barriers to timely and adequate treatmentDan Atar, Angelo Auricchio, Carina Blomström-Lundqvist
Pageof 41

Showing results (51-60 of 405) with videos related to

Sort By:
Pageof 41
Kardiologia Polska|May 6, 2022
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advancesDan Atar, Gisle Langslet, Serena Tonstad
Harefuah|November 8, 2002
[Fracture of the supracondylar process of the humerus associated with Monteggia fracture]Gad Kahn, Ehud Rath, Dan Atar
The New England Journal of Medicine|February 18, 2026
Beta-Blockers after Myocardial Infarction. ReplyJohn Munkhaugen, Dan Atar, Eva Prescott
Kardiologia Polska|May 5, 2023
Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarctionDan Atar, Arnhild Bakken, John Munkhaugen
Internal and Emergency Medicine|April 9, 2024
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigmAndrea Rubboli, Dan Atar, Dirk Sibbing
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 3, 2013
New oral anticoagulants--a reviewWaleed Ghanima, Dan Atar, Per Morten Sandset
The American Journal of Cardiology|March 14, 2007
Mechanism of troponin elevations in patients with acute ischemic strokeJesper K Jensen, Dan Atar, Hans Mickley
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 1, 2020
Intensification of antithrombotic therapy for chronic atherosclerosisMarita Knudsen Pope, Waleed Ghanima, Dan Atar
The American Journal of Medicine|July 30, 2019
Challenging Anticoagulation in Advanced Renal FailureHanz-Peter Marti, Victor Serebruany, Dan Atar
European Heart Journal|August 2, 2023
Cardiac device infection: removing barriers to timely and adequate treatmentDan Atar, Angelo Auricchio, Carina Blomström-Lundqvist
Pageof 41